[Latest] US Diabetes Devices Market Size/Share Worth USD 19.8 Billion by 2033 at a 7.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 23, 2024 13:30 ET
|
Custom Market Insights
Austin, TX, USA, July 23, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “US Diabetes Devices Market Size, Trends and Insights By Type (Blood Glucose...
GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR
June 13, 2024 09:19 ET
|
GlucoTrack, Inc.
Completion of the novel epidural continuous glucose monitoring study confirms its potential for providing simplified disease management for patients with painful diabetic neuropathy Rutherford, NJ,...
Clinical ink announces GlucoseReady™
April 23, 2024 08:00 ET
|
Clinical Ink
Winston Salem, NC, April 23, 2024 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, today announced the launch of GlucoseReady™, a fully integrated GCP compliant digital...
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
November 21, 2023 08:30 ET
|
Nemaura Medical, Inc
Loughborough, UK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital...
GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE
November 13, 2023 09:00 ET
|
GlucoTrack, Inc.
Rutherford, NJ, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with...
Durable Medical Equipment Market Size to Hit $291.52 Billion, Globally, by 2027 - Exclusive Report by The Insight Partners
September 20, 2023 10:29 ET
|
The Insight Partners
Pune, India, Sept. 20, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Durable Medical Equipment Market Forecast to 2027 – Global Analysis – by Device Type (Personal Mobility Devices...
Nemaura Medical Announces Participation at HLTH 2023, Las Vegas
September 12, 2023 09:26 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive...
Nemaura Medical Announces SFDA Approval of sugarBEAT®
August 17, 2023 08:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical Secures $6.5m in Non-Dilutive Funding
August 11, 2023 16:05 ET
|
Nemaura Medical, Inc
Loughborough, England, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
Nemaura Medical to Participate at the Collision Conference in Toronto June 26-29, 2023
June 22, 2023 08:00 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, June 22, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on non-invasive wearable sensors and personalized weight...